FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.)

Is this your podcast?

U.S. Food and Drug Administration, Center for Drug Evaluation and Research

FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.) is an FDA podcast series that provides information about new product approvals, emerging safety information for cancer treatments, and other current topics in cancer drug development.

Listen now

Ratings & Reviews

See all »

☆

4.2 stars from 9 ratings

Info on new cancer drugs

☆

“This is a very interesting podcast about important new drugs approved by FDA for cancer treatment.”

ASCOmember via Apple Podcasts · United States of America · 08/18/18

Kudos to the idea

☆

“Great thought”

Ashis p via Apple Podcasts · India · 07/06/18

MD (internal medicine), DM (medical & hemato-oncology)

☆

“Kudos to the wonderful minds behind creating this resource.”

Bhratri via Apple Podcasts · India · 01/13/18

Recent Episodes

See all »

FDA D.I.S.C.O. Burst Edition: FDA approval of Ojemda (tovorafenib) for relapsed or refractory pediatric low-grade glioma harboring a BRAF fusion or rearrangement, or BRAF V600 mutation

Listen to a soundcast of the April 23, 2024, FDA approval of Ojemda (tovorafenib) for relapsed or refractory pediatric low-grade glioma harboring a BRAF fusion or rearrangement, or BRAF V600 mutation.

Published 06/17/24

FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.)

Published 06/17/24

FDA D.I.S.C.O. Burst Edition: FDA approval of Enhertu (fam-trastuzumab deruxtecan-nxki) for unresectable or metastatic HER2-positive solid tumors

Listen to a soundcast of the April 5, 2024, FDA approval of Enhertu (fam-trastuzumab deruxtecan-nxki) for unresectable or metastatic HER2-positive solid tumors.

Published 04/26/24

Do you host a podcast?

Track your ranks and reviews from Spotify, Apple Podcasts and more.